Skip to main content

Table 2 Outcomes

From: Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study

End point

COVID-19 N = 146

H1N1 N = 162

Unadjusted hazard ratio (95% CI) COVID vs H1N1a

Adjusted hazard ratio (95% CI) COVID vs H1N1a,b

Mortality at 60 days, n (%)

67 (46)

43 (27)

1.76 (1.17–2.64)

1.39 (0.78–2.47)

Mortality at 90 days, n (%)

78 (53)

48 (30)

1.63 (1.11–2.41)

1.33 (0.78–2.30)

  1. aStratified per center
  2. bAdjusted for age, SOFA, SAPS II, sex, smoke, diabetes, chronic diseases, X-ray quadrants involved, rescue therapies pre-ECMO (LRM, prone position, inhaled NO), hospital LOS pre-ECMO, days of IMV pre-ECMO, ventilation setting pre-ECMO (VT/PBW, driving pressure, PaCO2, PaO2/FiO2)